Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
- 4 September 2007
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 77 (1) , 56-63
- https://doi.org/10.1016/j.antiviral.2007.08.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori , Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuniAntimicrobial Agents and Chemotherapy, 2007
- Nitazoxanide in the treatment of viral gastroenteritis: a randomized double‐blind placebo‐controlled clinical trialAlimentary Pharmacology & Therapeutics, 2006
- Nitazoxanide in the treatment of acquired immune deficiency syndrome‐related cryptosporidiosis: results of the United States compassionate use program in 365 patientsAlimentary Pharmacology & Therapeutics, 2006
- Effect of Nitazoxanide in Diarrhea and Enteritis Caused by Cryptosporidium SpeciesClinical Gastroenterology and Hepatology, 2006
- Effect of Nitazoxanide in Persistent Diarrhea and Enteritis Associated With Blastocystis hominisClinical Gastroenterology and Hepatology, 2005
- NM 283, AN EFFICIENT PRODRUG OF THE POTENT ANTI-HCV AGENT 2′-C-METHYLCYTIDINENucleosides, Nucleotides and Nucleic Acids, 2005
- Phosphorothioate Di- and Trinucleotides as a Novel Class of Anti-Hepatitis B Virus AgentsAntimicrobial Agents and Chemotherapy, 2004
- Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell CultureJournal of Virology, 2003
- Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d.Int. Journal of Clinical Pharmacology and Therapeutics, 2002
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998